Description
Seeking women with advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer for a study of different dosages and dosing schedules of an investigational drug.
Overview
Participants in this study will be split into two groups based on their liver function. The dose and schedule for getting an infusion of the investigational drug will depend on which group you are in.
What we're hoping for
We are studying the best dose of an investigational drug for advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer.
Additional Information
ClinicalTrials.gov Identifier: NCT06682988